Table of Contents
ISRN Genetics
Volume 2013, Article ID 609797, 10 pages
http://dx.doi.org/10.5402/2013/609797
Research Article

Genotyping of CYP2D6 Polymorphisms by MALDI-TOF Mass Spectrometry in Sardinian People

1PharmaNess S.c.a r.l., Parco Scientifico e Tecnologico della Sardegna, Edificio 5, Località Piscina Manna, 09010 Pula, Italy
2Unità Operativa di Cagliari, Parco Scientifico e Tecnologico della Sardegna, Istituto di Farmacologia Traslazionale del Consiglio Nazionale delle Ricerche CNR–IFT, Edificio 5, Località Piscina Manna, 09010 Pula, Italy
3Dipartimento di Scienze della Vita e dell’Ambiente, Laboratori di Genetica, Università degli Studi di Cagliari, Via T. Fiorelli 1, 09126 Cagliari, Italy

Received 7 March 2013; Accepted 4 April 2013

Academic Editors: B. Chen, M. A. Chiurillo, G. Giovambattista, and A. Yamamoto

Copyright © 2013 Matteo Falzoi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Ingelman-Sundberg, S. C. Sim, A. Gomez, and C. Rodriguez-Antona, “Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects,” Pharmacology & Therapeutics, vol. 116, no. 3, pp. 496–526, 2007. View at Publisher · View at Google Scholar
  2. M. Ingelman-Sundberg, “Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future,” Trends in Pharmacological Sciences, vol. 25, no. 4, pp. 193–200, 2004. View at Publisher · View at Google Scholar
  3. J. Ragoussis, “Genotyping technologies for all,” Drug Discovery Today: Technologies, vol. 3, no. 2, pp. 115–122, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Falzoi, A. Mossa, E. Congeddu, L. Saba, and L. Pani, “Multiplex genotyping of CYP3A4, CYP3A5, CYP2C9 and CYP2C19 SNPs using MALDI-TOF mass spectrometry,” Pharmacogenomics, vol. 11, no. 4, pp. 559–571, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Falzoi, L. Pira, P. Lazzari, and L. Pani , “Analysis of CYP2D6 allele frequencies and identification of novel SNPs and sequence variations in Sardinians,” ISRN Genetics, vol. 2013, Article ID 204560, 10 pages, 2013. View at Publisher · View at Google Scholar
  6. D. van den Boom and M. Ehrich, “Discovery and identification of sequence polymorphisms and mutations with MALDI-TOF MS,” Methods in Molecular Biology, vol. 366, pp. 287–306, 2007. View at Publisher · View at Google Scholar
  7. Human Cytochrome P450 Allele Nomenclature Committee, http://www.cypalleles.ki.se/.
  8. NCBI Single Nucleotide Polymorphism dbSNP, http://www.ncbi.nlm.nih.gov/projects/SNP/.
  9. J. Sistonen, A. Sajantila, O. Lao, J. Corander, G. Barbujani, and S. Fuselli, “CYP2D6 worldwide genetic variation shows high frequency of altered activity variants and no continental structure,” Pharmacogenetics and Genomics, vol. 17, no. 2, pp. 93–101, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Fuselli, I. Dupanloup, E. Frigato et al., “Molecular diversity at the CYP2D6 locus in the Mediterranean region,” European Journal of Human Genetics, vol. 12, no. 11, pp. 916–924, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Sachse, J. Brockmöller, S. Bauer, and I. Roots, “Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences,” American Journal of Human Genetics, vol. 60, no. 2, pp. 284–295, 1997. View at Google Scholar · View at Scopus
  12. S. Raimundo, C. Toscano, K. Klein et al., “A novel intronic mutation, 2988G>A, with high predictivity for impaired function of cytochrome P450 2D6 in white subjects,” Clinical Pharmacology and Therapeutics, vol. 76, no. 2, pp. 128–138, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. L. D. Bradford, “CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants,” Pharmacogenomics, vol. 3, no. 2, pp. 229–243, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Marez, M. Legrand, N. Sabbagh et al., “Polymorphism of the cytochrome P450 CYP2D6 gene in a European population: characterization of 48 mutations and 53 alleles, their frequencies and evolution,” Pharmacogenetics, vol. 7, no. 3, pp. 193–202, 1997. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Ingelman-Sundberg, “Implications of polymorphic cytochrome P450-dependent drug metabolism for drug development,” Drug Metabolism and Disposition, vol. 29, no. 4, part 2, pp. 570–573, 2001. View at Google Scholar
  16. T. Shimada, F. Tsumura, H. Yamazaki, F. P. Guengerich, and K. Inoue, “Characterization of (+/−)-bufuralol hydroxylation activities in liver microsomes of Japanese and Caucasian subjects genotyped for CYP2D6,” Pharmacogenetics, vol. 11, no. 2, pp. 143–156, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. ss469415642, CYP2D6 3176C>T, 2011, http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ss.cgi?ss=469415642.
  18. ss469415643, CYP2D6 3948T>G, 2011, http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ss.cgi?ss=469415643.
  19. I. Johansson, E. Lundqvist, M. L. Dahl, and M. Ingelman-Sundberg, “PCR-based genotyping for duplicated and deleted CYP2D6 genes,” Pharmacogenetics, vol. 6, no. 4, pp. 351–355, 1996. View at Google Scholar · View at Scopus
  20. QIAGEN LongRange PCR Handbook, 2008, http://www.qiagen.com/default.aspx.
  21. ss470263991, CYP2D6 -948C>A, 2011, http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ss.cgi?ss=470263991.
  22. M. Falzoi, L. Pira, P. Lazzari, and L. Pani, Homo sapiens haplotype 1 cytochrome P450 2D6 variant (CYP2D6) gene, CYP2D62M allele, complete cds, GenBank: JN716373.1, 2011, http://www.ncbi.nlm.nih.gov/nuccore/JN716373.1.
  23. M. Falzoi, L. Pira, P. Lazzari, and L. Pani, Homo sapiens haplotype 2 cytochrome P450 2D6 variant (CYP2D6) gene, CYP2D62M allele, complete cdsGenBank: JN716374.1, 2011, http://www.ncbi.nlm.nih.gov/nuccore/JN716374.1.
  24. M. Falzoi, L. Pira, P. Lazzari, and L. Pani, Homo sapiens haplotype 3 cytochrome P450 2D6 variant (CYP2D6) gene, CYP2D62M/CYP2D641 hybrid allele, complete cds, GenBank: JN716375.1, 2011, http://www.ncbi.nlm.nih.gov/nuccore/JN716375.1.
  25. M. Falzoi, L. Pira, P. Lazzari, and L. Pani, Homo sapiens haplotype 4 cytochrome P450 2D6 variant (CYP2D6) gene, CYP2D62M/CYP2D641 hybrid allele, complete cds, GenBank: JN716376.1, 2011, http://www.ncbi.nlm.nih.gov/nuccore/JN716376.1.
  26. P. Oeth, M. Beaulieu, C. Park et al., Sequenom Application Note, April 2005.
  27. iPLEX Gold Application Guide, 2009, http://www.sequenom.com/Files/Genetic-Analysis-Files/iPLEX-Application-PDFs/iPLEX-Gold-Application-Guide-v2r1.
  28. Sequenom Assay Designer Suite, https://seqpws1.sequenom.com/AssayDesignerSuite.html.
  29. Ensembl Genome Browser, http://www.ensembl.org/index.html.